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Abstract
From the ancient Romans, through the Middle Ages, to the late of the nineteenth cen‐
tury, the Aristotelian doctrine of spontaneous generation was one of the most basic laws. 
Even the invention of the microscope and investigations of Leeuwenhoek and Hook did 
not disprove the Aritostelian doctrine. Finally, in the eighteenth century, the spontane‐
ous generation doctrine was laid by Louis Pasteur. Moreover, in the first decade of the 
eighteenth century, nucleus was observed in plant and animal tissues, and Virchow and 
other scientists presented the view that cells are formed via scission of preexisting cells. 
In the first decade of the twentieth century, Ross Harrison developed the first techniques 
of cell culture in vitro, and Burrows and Carrel improved Harrison's cell cultures. In 
mid‐twentieth century, the basic principles for plant and animal cell cultures in vitro 
were developed, and human diploid cell lines were established. On the basis of knowl‐
edge about the cell cycle and gene expression regulation, the first therapeutic proteins 
were produced using mammalian cell cultures. The end of twentieth century and early 
twenty‐first century brought the progress in 3‐D cell culture technology and created the 
possibility of the tissue engineering and the regenerative medicine development.
Keywords: spontaneous generation, Harrison's hanging drop culture method, HeLa cell 
line, Hayflick limit, cell culture history
1. Introduction
At the present time, animal and human cell cultures are significant tools widely used in many 
branches of live science. Different variants of cell culture found application in modeling dis‐
eases, IVF technology, stem cell and cancer research, monoclonal antibody production, regen‐
erative medicine and therapeutic protein production. All those different scientific approaches 
would not be possible without some crucial discoveries that had been made over the centu‐
ries from Aristotelian spontaneous generation doctrine through Pasteur's experiments and 
Carrel's cell culture to large‐scale cultures for therapeutic proteins production and vision of 
© 2017 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativeco mons.org/licenses/by/3.0), w ich permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
the future of regenerative medicine and in situ bioprinting of wounds. The main milestones 
in cell cultures are presented in proposed chapter (see Figure 1).
Figure 1. Timeline: key milestone in cell cultures.
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2. Live under the microscope
The development of biological sciences would not have been possible without one of the 
greatest inventions—microscopes. In the sixteenth and seventeenth centuries—two coun‐
tries—the Netherlands and Italy played a crucial role in constructing and using microscopes 
and telescopes. In the Netherlands, around 1590, Hans Janssen and his son invented a com‐
pound microscope—constructed of two convex lenses. In the early 1600s (about 1610), the 
great Galileo Galilei (1564–1642) constructed several simple microscopes and telescopes, 
which he called as “occhialino.” The term “microscope” was used for the first time in 1625 by 
the Italian physician Giovanni Faber [1].
The first publication, in which Petrus Borellus described the use of microscope in medi‐
cine, was written in 1653. He presented 100 microscopic observations and applications (e.g., 
removing ingrowing eyelashes invisible with the naked eye). In 1646, Athanasius Kircher 
(1601–1680), a Jesuit priest, described that “in the blood of fever patients a number of things 
might be discovered.” Kicher showed later (in 1658) that maggots and other living crea‐
tures (some of them he called microscopic “worms”) occurred and developed in decaying 
tissues [1–3]. Two other microscopists—Swammerdam (1637–1680) in 1667 and Malpighi 
(1628–1694)‐characterized red blood cells [1,2]. In Bologna, another scientist, Joseph 
Campini, illustrated the first use of the microscope in the clinical examination of a wound 
on the leg of a patient [1, 4].
At the beginning of the seventeenth century, two inventors—Robert Hook (1635–1702) and 
Antonie van Leeuwenhoek (1632–1732)‐made an unusual discovery. Both of them made their 
first observations of life under the microscope and made the previously invisible microscopic 
world real [3].
The English physicist, Hooke, published in 1665 the first important work on microscope 
construction, its components and microscopic observations. In his Micrographia, he illus‐
trated microscopic structures of many biological samples (e.g., insects, plants, sponges, 
bryozoans, fossils), as observed through microscopes and described the microscopic units. 
The “cells” or “pores”, as he called small compartments of a slice of cork (thickened walls 
of dead cells) were chosen to refer to these microscopic units. Although Robert Hooke used 
the term “cell” differently compared to the later biologists, the today's term “cell” comes 
directly from Hooke's Micrographia [3, 5, 6].
In 1676, the Royal Society (RS) received a letter from Antonie van Leeuwenhoek, in which 
the microscopist had described his exciting discoveries—observations and records of small 
living particles. These microorganisms, which Leeuwenhoek called “animalcules,” were 
mainly protozoa and bacteria [3, 4]. Implementation of his scientific project was inspired 
by the Hooke's bestseller, Mircographia. He started by handcrafting lenses and constructing 
microscopes (he was known to make over 500 microscopes). The Leeuwenhoek's single lens 
microscopes were smaller than magnifying glasses (3–4 inches long) but were capable of 270× 
magnifications or even more (while the Hooke's microscopes could only achieve magnifica‐
tions of about 50×), with clear and bright images. The observed specimen was mounted in 
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front of the lens on a spiked screw [4]. Leeuwenhoek began his microscopic observations with 
insect samples (e.g., parts of bees) and continued with observations of spirogyra, vorticella, 
protozoa and motile bacteria (e.g., from the human mouth). He also examined many human 
and animal tissue samples, and he described blood cells (for the first time illustrated in his 
Arcana in 1695), sperm cells (he called semen “sperm animals”), skeletal muscle fibres, epithe‐
lial cells, teeth and circulatory system structures. He was the first to use histological staining 
(he stained muscle tissue with saffron) and described most of his observations (most of them 
involved microorganisms) in 560 letters to the Royal Society (RS) during his lifetime, and thus, 
he became the “Father of Microbiology” [1, 3, 4, 7].
Since Leeuwenhoek's invention microscopes have been one of the most fundamental tools, 
particularly, in the biological sciences, but also in clinical pathology and medical diagnosis 
[8]. In the twentieth century, many discoveries have been made in the field of life sciences, 
due to modern microscopy techniques. In 1941, Fritz Zernike constructed first phase con‐
trast microscope. Another invention was a microscopic differential interference contrast tech‐
nique (phase contrast) evolved by Georges Nomarski. Invention of fluorescence and confocal 
microscopy revolutionized life sciences. Confocal scanning microscopy gives possibility to 
examine fixed or alive biological specimens. This technique allows the selective and specific 
detection and visualization of molecules at small concentrations with good signal‐to‐back‐
ground ratio [8]. Technique of confocal microscopy was evolved by Marvin Minsky in 1957 
[9]. Confocal scanning microscopy technique is based on the restriction of photodetection to 
light originating from the focal point, whereas in fluorescence microscopy, the entire sample 
is excited indiscriminately, where the fluorescent photons arise from out‐of‐focus fluorofores. 
The optical sectioning gives three‐dimensional microscopic reconstruction of biological sam‐
ples. For photodamge and photobleaching reduction, the confocal microscopy was improved 
by the use of spinning disk scanners that were based on the disk invented by Nipkow (in 
1884). Use of many pinholes enhances detection of the fluorescence and reduces excitation [8].
The fluorescent microscopy was also revolutionized by the two‐photon microscopy inven‐
tion. In this technique, two‐photon excitation is applied, that means that using ultrafast laser 
(infrared) is possible to obtain locally very high photon concentration that occurs only at the 
focal point of the microscope. The two low‐energy photons excite together a chromophore 
(only at the scan plane) and generate fluorescence. Use of infrared results in lowering the light 
scattering cross section of living tissues, which gives possibility to examine fluorophores deep 
in living samples. In contrast to confocal microscopy, the two‐photon microscopy ensures 
that the problem of photodamage and photobleaching is reduced, but disadvantage of that 
method is worse spatial resolution in comparison with confocal microscopes [8]. In the 1990s, 
Stefan Hell developed super‐resolution fluorescence microscopy technique and gave the sci‐
entists possibility to examine structures of the size of a few nanometers.
Immunofluorescene techniques with the new fluorescence molecules (immunofluorescence 
reagents, organic dyes, quantum dots) and discovery of fluorescent proteins (e.g., GFP) and 
use of confocal microscopy made new possibilities to examine biological specimens [10, 11]. 
For example, confocal microscopy allows the live‐cell imaging (time‐laps microscopy) to 
monitor cell movements, cell and tissue structures in one (1‐D), two (2‐D), three (3‐D) spatial 
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dimensions or 4D—(3D × time) [12]. The variant of live‐cell imaging techniques—fluorescence 
loss in photobleaching (FLIP)‐utilizes repeated photobleaching that can be used to assess the 
continuity of membrane of endoplasmic reticulum or Goligi apparatus. Fluorescence reso‐
nance energy transfer (FRET) technique gives opportunity to display interactions between 
two molecular species. The energy transfer from fluorescent “donor” to fluorescent “accep‐
tor” is possible when fluorofores are in nanometer proximity [12].
Using fluorescent dyes, it is possible to label live or death cell nuclei, for example, SYTO59 
or SYTO61 for live cells, DAPI, popidium iodide (Figure 2), Sytox Green or T0‐Pro‐3 for the 
nuclei of death cells [12], and fluorescently labeled antibodies used for, for example, HeLa cell 
mitoses with anti‐tubulin staning [13], anti‐cytokeratin staining (Figure 2).
Cellular junction identification is based on detection of structural components and proteins 
that are associated with those components. For studying cell adhesion and cellular junctions 
monoclonal, polyclonal antibodies labeled with conjugates for visualization of the target cel‐
lular structures are used for gap junction‐Connexin‐40, CX40; Connexin‐43, CX43; pannaxin 
(1, 2) for synapses; for tight junctions (TJ)—claudins, occludins, JAMs (junctional adhesion 
molecules) and CRB1 (human Crumbs homolog 1); for adherents junctions—cadherin‐
catenin‐actin modules; for desmosomes and hemidesmosomes—cadherins (desmoglesins 
and desmocllins) and intergins [15–17].
Mentioned techniques can be used for determination of ion concentration, for example, pH, 
Ca2+, K+, Na+, O
2
, in biological systems (for example within cells) [18]. Many of fluorescence 
probes are ion indicators with a different fluorescence lifetime (τ
f
) of the free form of probes 
and the form bound to ions. This property allows to selective and quantitative imaging of sev‐
eral different ions (pH, Ca2+, K+, Na+) in the same time. The intracellular pH determination is 
commonly analyzed using c‐SNAFL‐1 fluorescence probe. Different values of τ
f
 for bounded 
and unbounded form of fluorophore and different emission spectra are measured. The Ca2+ 
determination can be performed with the [Ca2+]‐sensitive probe Fluo‐3 or indo‐1. The Fluo‐3 
Figure 2. Bovine mammary epithelial cells immunostained against cytokeratins and DAPI‐stained nuclei (confocal laser 
scanning microscopy, 400×) (A). Dome structures stained with propidium iodide (confocal laser scanning microscopy; 
magnification, 600×) (B) [14].
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reacts on the presence of Ca2+ ions, the higher intensity of fluorescence, the higher Ca2+ con‐
centration [18], whereas the O
2
 concentration analysis is based on reduction of τ
f
 that can be 
also used for imaging purposes [18].
Using modern microscopy technique gives the possibility to study cell structures, motil‐
ity of cells and organelles, cell‐cell communication and membrane potential in single cells. 
Microscopic techniques found important application in biomedical field (e.g., confocal endo‐
microscopy, oftalmology) [19, 20].
The live cells in vitro and in vivo imaging techniques accelerate drug discovery. Real‐time 
imagine provides analysis of drug response upon target activity and pathophysiology and 
results in higher clinical predictivity [21]. Based on in vitro model, the monitoring of cellular 
phenotypes within complex samples such as co‐cultures, 3‐D culture models, is now possible. 
Cell attachment, migration (velocity, direction), vesicle formation, angiogenesis, stem cell dif‐
ferentiation can be recorded using automated imaging platforms [21, 22].
Some of them are based on the label‐free phase holographic microscopy. In this technique, 
the low‐power (635 nm) red diode laser divided into two beams—reference and an object 
beam—that passes through the unlabeled cell cultures on T‐flask surface merged together can 
be recorded as the hologram imagines (Figure 3) [23–25].
Another microscope—the atomic force microscopy (AFM)‐gives unique possibility to visual‐
ize structure, topography (Figure 4) and examine mechanical properties of cells (e.g., adhesion 
force distribution, cells stiffness—Young's modulus as a biomarker of the relative metastatic 
potential).This method is a variant of scanning probe microscopy that demonstrated better 
resolution, than the optical diffraction limit [26].
Figure 3. Cell cultures visualized using label‐free holographic microscopy. L929 fibroblast cell line, 200× (A). MCF‐7 
adenocarcinoma cell line, 200× (B) [unpublished, Luzny and Jedrzejczak‐Silicka].
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3. The end of spontaneous generation
From the ancient Romans, through the Middle Ages, to the late of the nineteenth century, the 
Aristotelian doctrine of spontaneous generation was one of the most basic laws in biological sci‐
ences [3]. This idea was presented for the first time by Aristotle in his History of Animals, where 
he described the generation of insects from animal flesh, mud, and other organic and inorganic 
matter [27]. According to this thesis, non‐living matter (water, land or hay) bears the potential 
to generate spontaneously different and complex organisms. For example, in the seventeenth 
century literature, recipes for mice were known—the mixture of old shirts and wheat placed in a 
jar for 21 days produced mice [28, 29]. Even the invention of the microscope and investigations of 
Leeuwenhoek and Hook did not refute the Aritostelian doctrine. The existence of micro‐organ‐
ism—protozoa, and unicellular living organisms was a specific link between the inanimate sub‐
stance and living organisms, and perversely, supported the spontaneous generation doctrine [3].
The first attempt to verify the idea of spontaneous generation was made by an Italian physician 
Francesco Redi (1626–1697). In 1668, Redi tested his hypothesis (described in the “Experiments 
on the Generation of Insects”) that maggots did not arise spontaneously in decaying tissues 
Figure 4. The peripheral MAC‐T—bovine mammary epithelial cell margin recorded using atomic‐force microscopy 
(AFM). AFM height image (A). AFM height image—3‐D image (B). MAC‐T cell height measurements (C and D) 
[unpublished, Jedrzejczak‐Silicka].
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(rotting meat) but developed from fly eggs. In his experiment, Redi prepared three variants 
of flasks with meat [27, 28]; some flasks were open to the air, some were completely sealed 
and the third variant was covered only with a gauze. According to his expectations, maggots 
appeared only in completely open flasks, in which the flies laid their eggs. Although Redi's 
experiment proved that maggots did not appear in meat if flies were kept away by the seal or 
gauze, the idea of spontaneous generation was still strongly believed. Even Redi believed that 
spontaneous generation was possible under some circumstances, for example, insects—gall 
flies—were generated by abnormal growths of plant (galls) itself [27–30].
This theory was disproved by the Italian naturalist Lazzaro Spallanzani (1729–1799) in the 
mid‐eighteenth century. In his masterful experiments, he showed that an organism was 
derived from another living organism(s), and he confirmed that there was a gap between 
inaminate matter and living organisms [3]. He repeated the experiments of English priest 
and biologist John Turberville Needham. In 1745, Needham started his experimentation after 
reading about Leewenhoek's animalcules in the letter to RS [31]. He observed the growth of 
microorganisms in chicken broth placed in the sealed flask and heated for 30 min [31]. This 
result seemed to validate the Aristotelian doctrine of spontaneous generation; Spallanzani 
was intrigued, but not convinced, and suggested that microorganisms had not appeared 
spontaneously after the boiling process but had entered the broth from the air before the flask 
was sealed [28]. He found significant errors in Needham's experiments and modified previ‐
ous technique on the basis of his own several hundred experiments. He placed the broth in 
the flask, sealed the flask, created a partial vacuum and then boiled the broth [28]. The results 
of the experiments clearly demonstrated that the infusoria (a class of aquatic microorgan‐
isms, including primarily the organisms which now are classify as Protista) did not generate 
spontaneously in sterilized flasks [27]. His assiduity earned him success in disproving the 
validity of the theory of spontaneous generation, but even supporters of empirical evidence of 
spontaneous generation argued that he had only proven that spontaneous generation could 
not occur without air [28, 31, 32].
Finally, the spontaneous generation doctrine was laid by Louis Pasteur (1822–1895) [3]. 
Between 1860 and 1862, the young French chemist performed a lengthy series of experiments 
that were a variation of Needham and Spallanzani methods. His experiments focused on the 
development of microbes in the previously boiled infusions. Pasteur’ s experiments were per‐
formed in a series of flasks with their necks heated in a flame and drawn out into a long “S” 
shape, like a “swan neck.” The “swan‐necked flasks” were prepared after flasks had being 
filled with the pre‐boiled infusion (liquid was heated to 100°C and boiled for several min‐
utes) [30, 33]. Air could enter to such a flask, but not micro‐organisms. When Pasteur tilted 
the flask, the broth reached the lowest point in the neck and airborne microorganisms could 
have settled by the gravity. In addition, when the neck was broken off, the dust particles 
entered the flasks [28, 30]. The effect of this action was rapidly visible—the yeast/sugar water 
infusion became cloudy with microbes. Based on the obtained results, Pasteur concluded 
that microbes and their germs were carried out with the dust particles. When the dust was 
excluded, the infusoria was not altered. This experiment not only refuted the theory of spon‐
taneous generation, and proved that the living matter can only arise from pre‐existing life, 
but also demonstrated that micro‐organisms are omnipresent—even in the air [28, 30]. Even 
New Insights into Cell Culture Technology8
after the presentation of Pasteur's result, some of his opponents suggested that his experi‐
ment proved only that dust was necessary for spontaneous generation [30]. But what would 
have happened if Pauster had tried his famous experiment with the “swan‐necked flasks” 
and boiled hay infusion? About a decade later, it was found that the hay bacillus—Bacillus 
subtilis—produced heat‐resistant endospores; therefore, the result of the experiment could 
have been different, and the discussion about the theory of spontaneous generation might 
have not had ended [30].
The results obtained by Pauster were validated in practice by Lister (1827–1912). Pauster's 
conclusions about the prevalence of microorganisms in the air were taken into account in his 
pioneering antiseptic surgical procedures [34]. Lister suggested that microorganisms caused 
infection and gangrene similarly to Pasteur's fermentation process [36, 37]. He prevented 
wound infections in his patients using spray (Richardson's hand spray) and a solution of 
carbolic acid as an antibacterial agent. Lister later used in his aseptic methods a large hand‐
operated tripod to achieve germ‐free conditions [34, 35]. Thanks to this technique, the end of 
the nineteenth century was the beginning of aseptic surgery and also symbolically the end of 
the Aristotelian doctrine.
4. The cell theory
At the same time, when the great debate about the spontaneous generation was held, other 
observations were made focusing on cell components and organization of the living mat‐
ter. In the first decade of the eighteenth century, nucleus was probably observed in plant 
and animal tissues, but the first description of nuclei in epithelial cells was made by Felice 
Fontana (1730–1805) and published in 1781 in the Traitésur le Vénin de la Vipére [3, 37]. The 
term “nucleus” (literally “little nut” in Latin) was introduced 50 years later, in 1831, by the 
distinguished Scottish botanist Robert Brown (1773–1858). On the basis of his microscopic 
observations of orchid leaves, Brown found that this structure is essential in living cells. He 
described the nucleus as “a single circular areola generally somewhat more opaque than, the 
membrane of the cell, is observable…. This areola, or nucleus of the cell, as perhaps it might 
be termed, is not confined to the epidermis, being also found not only in the pubescence of 
surface, particularly when jointed, as in Cypripedium, but in many cases in the parenchyma or 
internal cells of the tissue” [3, 38–40]. In his publication (1827), Brown also described the first 
observation of Brownian Movements in Clarkia pulchella pollen [39, 41].
Technical improvements in microscope constructions helped in 1838 the botanist Matthias 
Schleiden (1804–1881) and in 1839 the zoologist Theodor Schwann (1810–1882) to formulate 
the “cell theory” [3, 42]. They suggested that every organism and every structural element of 
plant and animal tissues are formed of cells. Schleiden studied the structure of plant tissues and 
concluded that all plant structural elements are composed of cells or their products. He also 
properly noticed that the “increase in the size and number of cells is responsible for growth” 
[43]. Although his atomistic conclusion of the “cell theory” was proper, the reminiscence of the 
“spontaneous generation” doctrine influenced his theory of “free cell formation.” According 
to this theory, the formation of a nucleus of “crystallization” within the cytoblast was the first 
History of Cell Culture
http://dx.doi.org/10.5772/66905
9
phase of cell generation. Subsequent to nucleus formation was the enlargement of condensed 
material leading to the formation of a new cell [3]. This theory of “free cell formation” was 
rejected by scientists of that time—Robert Remark, Rudolf Virchow, Albert Kölliker [3].
A year later, Schwann examined animal tissues and also observed that “the elementary parts 
of all tissues are formed from cells” and that “there is one universal principle of development 
for the elementary parts of organisms…and this principle is in the formation of cells” [3, 44]. 
He argued that even “the highly differentiated organisms (plants and animals)…are the for‐
mation of cells.” In his Untersuchungen, he wrote that “the tissues of animals are formed of 
cells. The globules of lymph, pus and mucus are cells with their walls distinct and isolated 
from each other. Horny (squamous) tissues are cells with distinct walls, but united into coher‐
ent tissues; bone and cartilage are formed of cells whose walls have coalesced; fibrous tissue 
and tendon are cells which have split into fibres; and muscle, nerves and capillary vessels are 
cells of which both the walls and cavities have coalesced” [43, 44]. Schwann defined that a cell 
has three essential elements—nucleus, a fluid content and a wall (or membrane) [43, 45, 46]. 
Other fundamental principle formulated by Schwann (partially as a token of gratitude to his 
colleague Schleiden) determined that the “cells arise inside and near other cells by differen‐
tiation of a homogenous primary substance called the “cytoblastema” in a process analogous 
to crystallization” [47, 48]. After Schwann's conclusion pertaining to morphological units 
of tissues and organs, two histopathological atlas texts were published by Julius Vogel and 
Herman Lebert. Eventually, the formulation of the “cell theory” provoked the scientist in 
the nineteenth century to verify the Aristotelian doctrine and accepted the “cell theory” as a 
scientific fact [42].
Meanwhile, Virchow and other scientists presented the view that cells are formed via scission 
of preexisting cells. Virchow formulated (influenced by Remark) an aphorism—omnis cellula 
e cellula (published in 1855)—that became crucial in the theory of tissue formation and part of 
the biogenic law. He stated in 1858 that “where a cell exists, there must have been a preexist‐
ing cell, just as the animal arises only from an animal and a plant only from a plant” [3, 49, 
50]. The cell was described as the fundamental unit of life, but also the basal element of path‐
ological processes. In his publication—Cellularpathologie—he created a pathogenic concept 
that all diseases are the result of changes in normal cells [3, 49]. In the publication of Cellular 
Pathology (1863), Lecture III is titled “Physiological and Pathological Tissues” and in it Rudolf 
Virchow tried to explain problem of the pathological tissues, called by him “neoplasm.” In 
his work he stated that “…every pathological structure has a physiological prototype, and 
that no form of morbid growth arises which cannot in its elements be tracked back to some 
model which had previously maintained an independent state in the economy.” In that state‐
ment the physiological prototype is healthy or normal state. The diseases state as opposed 
to normal state was described as “…a physiological type can be found for every pathologi‐
cal formation, and it is just as possible to discover such types for the elements of cancer….” 
The transition from the healthy to the neoplastic state is the effect of mutation (now we use 
the term—somatic mutation). In his work, the term “histological substitution” was used to 
describe that can occur in diseased conditions—“…a given tissue is replace to another; but 
even when this new tissue is produced from the previously existing one, the new formation 
may deviate more or less from the original type. Therefore, there is a great chasm between 
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physiological and pathological substitutions, or at least between the physiological and cer‐
tain forms of the pathological ones.” In 1859, Virchow advanced his theory that abnormal 
changes in the cells derived by common descent from a “germ cell” could lead to a disease 
such as cancer. The “pathological substitution” and cancers Virchow indentified histologi‐
cally as lines of cells with “bad behaviour” and presented the human diseases as a result of 
“civil war between cells” [51].
On the contrary, Louis Pasteur developed the germ theory of diseases. Pasteur's theory was 
rejected in its entirety by Virchow who was convinced that the diseased tissue was caused by 
changes within healthy cells, but not from invasion of other organisms [49]. Virchow tried to 
understand the nature and origin of cancer, and some of his theories were correct; neverthe‐
less, Pasteur was also right about the causality of diseases [45, 49, 51].
5. Harrison's hanging drop technique and Dr. Carell's immortal cells
In the late nineteenth century, Wilhelm Roux (185–1924) demonstrated that it is possible to 
maintain living cells (of the neural plate of chick embryos) outside the body in saline buffer 
for a few days [52].
At the same time, Leo Loeb (1869–1959) evaluated a technique called “tissue culture within 
the body.” In this technique, Loeb was able to culture cells from inside and outside body tis‐
sues. For example, he placed skin fragments of guinea pig embryo in agar and coagulated 
serum, then grafted them into adult animals. Using this procedure, Loeb obtained reproduc‐
tion of mitotic epithelial cells. This technique was not strictly considered as a classical cell and 
tissue culture, due to grafting tissues and fluids in living animals [52, 53].
The American embryologist Ross Granville Harrison (1870–1959) developed the first tech‐
niques of cell culture in vitro in the first decade of the twentieth century [52–56]. In Harrison's 
experiments (1907–1910, at the Yale University), small pieces of living frog embryonic tis‐
sue were isolated and grew outside the body. He placed the tissue in a solution of lymph 
on a coverslip, inverted the material on a glass slide with a depression in it and maintained 
the explanted tissue in a hanging drop [54, 57]. Harrison's method, although adapted from 
microbiological technique and used for bacteria studies (invented by Robert Koch in the 1880s 
and first used for anthrax bacilli growth), was successfully applied to cell cultures [52, 54]. 
Harrison's experimentations made the cell life “visible.” In his research article “Observations 
on the Living Developing Nerve Fiber,” he described a method of maintaining nerve cells 
and was able to monitor fiber development [52, 58–60]. He noted “the development of the 
nerve fibers by independent growth from cells outside the body” [59]. The development of 
the nerve fiber was a continuous process from a single cell, in parts from chain of cells, or pro‐
gressed within plasmatic bridges that remained between embryonic cells after their division 
[54, 60]. The use of a clotted lymph and special technique helped Harrison in the presenta‐
tion of nerve outgrowth from tissue explants into the medium, but unfortunately, Harrison's 
observations were time‐limited by rapid bacterial contaminations. For that reason, Harrison 
introduced aseptic techniques in working with cell cultures. The glassware was flamed, 
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chirurgical equipment (e.g., needles, scissors and forceps) was boiled, and the cloths and filter 
papers were autoclaved. Aseptic technique made it possible to obtain sterile preparations that 
could be maintained in vitro for over five weeks. Due to changes in sterile tissue preparation, 
Harrison was able to report various stages of cell development in a continuous manner over 
time. Drawings of observed nerve fibers were made with a camera lucida [54]. Thanks to the 
development of his technique, Harrison shed light on enormous possibilities of cell and tissue 
culture application not only as a tool in bacteriology, embryology, physiology or histology 
studies, but also the production of monoclonal antibodies, vaccines and drugs [52].
In 1910, Montrose Burrows (1884–1947) visited Harrison at Yale and adapted the method of 
hanging drop cell culture to his experimental requirements [58, 59]. Burrows worked with 
warm blood tissues, in which the chicken plasma clot was used [54]. Plasma was much easier to 
obtain and was more homogenous in quality, and thus, the preparation process was more reli‐
able [52]. Then, together with Alexis Carrel (1873–1944) at the Rockefeller Institute for Medical 
Research in New York, they established cell cultures of embryonic and adult tissues (connec‐
tive, periosteum, cartilage, bone, bone marrow, skin, kidneys and thyroid gland) of many 
species (e.g., dog, cat, chicken, guinea pig, rat) that could be maintained in vitro, due to the 
“plasmatic media”—fresh plasma from the same source as the tissues [52, 61, 62]. Burrows and 
Carrel evaluated other culture media composed of diluted plasma with different salt and serum 
solutions [52, 63]. Using complex media, they were able to subculture and maintain cultures 
for several months. They worked not only with normal adult mammalian tissues, but also with 
cancerous tissues. Those changes distinguished Burrows and Carrel's cultures from Harrison's 
and gave them the possibility to introduce the idea of continuous culture—obtaining new cul‐
tures from the old ones, without establishing primary cultures from new tissue explants [54, 
64]. The results obtained by Carrel and Barrows were published in the Journal of the American 
Medical Association in 1910, and the term “tissue culture” was defined for the first time in 1911 
as “a plasmatic medium inoculated with small fragments of living tissues.” The introduced 
term “tissue culture” described also the growth and reproduction outside the body [54, 60].
In January, 1912, Carrel and his coworkers developed the first “cell line” derived from the 
fragments of explanted chicken embryo heart [52, 61]. This cell line was subcultured hun‐
dreds of times, and after the initial contamination outbreak, it was continued by Arthur 
Ebeling in Carrel's laboratory. This cell line was maintained by washing with Ringer's solu‐
tion and medium changes [65, 66]. Due to the rigorous aseptic techniques, this is one of the 
most famous cell lines (described in many articles, e.g., cell line birthday was celebrated annu‐
ally in the New York World Telegram); it was maintained until 1946 when the cell line culture 
was finally terminated, 2 years after Carrel's death [61]. Carrel's cell line was a phenomenon 
for scientists. Indefinite growth of Carrel's cells was evident, and it was defined that cells 
could live indefinitely except for some lethal circumstances [67, 68]. Problems with obtaining 
indefinite growth of cells were attributed to the inadequacies of the technique. In 1956, Haff 
and Swim described cell aging in vitro, but they stated that their failure to obtain an immortal 
cell line was caused by deficiencies in the culture medium [67, 69].
The success of Alexis Carrel and his laboratory was not only possible due to the rigorous asep‐
tic techniques, but also due to the development of first practical cell culture flasks (in 1923), 
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which were called “D flasks”. This culture flask (also called a D‐3.5 flask) had a diameter of 
3.5 cm and was made of PYREX glass. New cell culture flasks allowed to culture cells in a 
larger medium volume and made culture maintenance much easier [61].
In 1938, Carrel published the book “The culture of organs,” in which he presented the culti‐
vation techniques of whole organs. Carrel started a collaboration with Charles A. Lindbergh 
in 1930. They worked on the process of organ perfusion, such as whole heart perfusions of 
cats and kittens. Organ perfusion was carried out through the aorta with Tyrode's solution 
supplemented with 50% serum at 37°C [62, 65, 66].
6. Evaluation of cell culture techniques and establishing principles in cell 
culture maintaining
The early of twentieth century was the time when the basic principles for plant and animal cell 
cultures in vitro were developed [70]. Evaluation of cell culture knowledge was possible not 
only due to hanging drop culture technique. The significant impact on cell culture develop‐
ment had introduction of the aseptic techniques and Rous and Jones tissue trypsinization tech‐
nique [70–72]. Rous and his colleague found that use of trypsin solution results in obtaining 
single cell suspension and cells detachment for subculture. The 3% trypsin solution was used 
successfully for plasma digestion and did not damage most cells. When 5% trypsin solution 
was tested, obtained cells were dead [72]. Until then, cultures were obtained from the tissue 
explants, and use of trypsin facilitated procedure of obtaining homogenous cell strains [73].
6.1. Cell line cultures development
The first cell line—the “L” cell line—was established by Earle in 1948. This cell line was 
derived from subcutaneous mouse tissue [70, 71] and displayed quite different morphology 
from the origin of tissue [70].
In 50s and 60s, another diploid cell lines were developed—HeLa (by Gay, see subsection 
7) MRC‐5 (by Jacobs) and WI‐38 (by Hayflick and Moorhead) from human tissue and Vero 
(Verde—French for green and RenO—French for kidney) cell line obtained from simian tissue 
[70, 74]. The examples of the earliest derived cell lines are presented in Table 1.
The establishment of cell lines gives possibilities to determine differences between cell lines 
culture and the primary cell cultures. The primary cell cultures are obtained directly from the 
tissues or organs and are considered primary until the first passage (subculture). The primary 
cell cultures are mainly initiated from normal or malignant adult tissues and embryonic tis‐
sues. The population of cells in primary cultures prepared by tissue disruption (using enzy‐
matic or/and physical methods) is mixed and contains different cell types. This type of culture 
is used in many areas such as physiology and cellular metabolism, cytogenetics, pharmacol‐
ogy or tissue engineering [70, 76]. Subculture technique allowed researches to obtain cell lines 
by serial subculture cells from primary cell cultures. The cell lines established from normal 
tissues display finite growth (see Section 6.3—Hayflick phenomenon). In the contrary, cell 
lines obtained from cancerous tissues were able to indefinitely proliferation. The indefinitely 
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proliferation of cells from normal tissues was also described and was in general the result of 
spontaneous transformation (see Section 8). Different cell lines are commonly used in many 
valuable studies, but use of cell lines also has same disadvantages and limitations, especially 
in drug development. The main disadvantages and limitation of using cell lines are listed 
below:
• The genetic aberrations of cell lines related with increasing passage numbers,
• The genotypic and phenotypic drift in continuous cultures, especially deposited in cell 
banks for many years,
• The cell line response toward the tested drug might be different form patient response 
toward the same drugs,
• Different microenvironments of the original tumor and cancer cell cultures (2D and 3D),
• Cross‐contamination of cell cultures with HeLa cell line (it was reported that a large num‐
ber of cancer cell lines are cross‐contaminated),
• Culture conditions can change the morphology, the gene expression and several cellular 
pathways,
• Infections with mycoplasma that can change the culture properties,
• Difficulty in the establishment of long‐term cancer cell lines of certain types of tumors,
• Cell culture environment is different from that of the original tumor,
• Loss of the natural heterogeneity of the tumor or tissue [77, 78].
Name Species and tissue Morphology Author and year of origin
L929 Mouse connective tissue Fibroblast Earle, 1948
HeLa Human cervix Epithelial Gay, 1951
CHO Chinese Hamster ovary Epithelial‐like Puck, 1957
MDCK Canine kidney Epithelial Madin and Darby, 1958
WI‐38 Human lung Fibroblast Hayflick, 1961
BHK‐21 Syrian Hamster kidney Fibroblast Macpherson and Stoker,
1961
Vero African Green Monkey 
kidney
Epithelial Yasumura and Kawakita, 1962
NIH 3T3 Mouse embryo Fibroblast Todaro and Green, 1962
MCR‐5 Human lung Fibroblast Jacobs, 1966
SH‐SY5Y Human neuroblastoma Neuroblast Biedler, 1970
Table 1. Commonly used cell lines [75].
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6.2. Cell culture conditions
On the basis of different experiments on cell cultured in vitro, the conditions and physico‐
chemical properties of environment for the growth and maintenance of human and animal 
cell cultures were established (see Table 2).
In the 1920s, composition of salt solutions was formulated specifically for cell cultures, 
for example, Pannett and Compton (1924), Gay (1936), Earle (1943) or Hanks salts (1948). 
Establishing formulas of salt solutions was the first step to define cell cultures requirements. 
The scientists indentified the most needed components for cellular metabolism, such as amino 
acids, salts, vitamins, hormones and glucose. Between 1932 and 1962, about 60 chemically 
defined media were worked out [80], for example, Morgan, Morton and Parker develop 
media199, and Earle and his coworkers worked out protein free media for L cell culture. 
In that time, EM medium—Essential Medium, and DMEM—Dulbecco Modified Eagle's 
Medium, were also develop with essential and nonessential amino acids [71]. Media were 
also divided into two types of media that were worked out—media for long‐term and short‐
cultivation, for example, Trowell's medium T8 (1959) for organ culture [80, 81]. In 50s and 60s, 
different scales (small and large scale) of cell cultures were worked out. The large‐scale cell 
culture development has allowed the creation of Salk vaccine for polio infection. The polio 
virus was cultured in simian and human kidney cells [70].
Nowadays, cell culture media are usually supplemented with the antibiotics, but first effect 
of antibiotics on cell cultured in vitro was established in the 1940s. Herrell and coworkers 
found that the different preparation of penicillin exhibited toxic action on mitosis due to some 
impurities in penicillin preparation. In the comparison with penicillin G, it was practically 
harmless for cells [82, 83]. Keilova presented in her work influence of streptomycin directly 
on the explants of heart, aorta and frontal bone of the chick embryo [84]. It was also found by 
Lawrence that in higher concentration, antibiotics (including penicillin, streptomycin, tetracy‐
cline and neomycin) affected not only migration of epithelium around skin explants, but also 
in some concentrations caused respiratory damage or necrotic changes [83]. In other study, 
Krueger analyzed effect of streptomycin on protein synthesis in mammalian cells and found 
that this antibiotic altered the in vitro synthesis of antibody to phage MS‐2 in spleen and 
lymph node cells from immunized rabbits [85].
For protection or for cleaning up the cell cultures, combining of antibiotics with specific antisera 
or chemical can be used [86]. For fungus or yeast antifungal agents, for example, Amphotericin 
B (Fungizone) and Nystatnin can help to prevent their growth but will not eliminate them [86]. 
Mycoplasmas are theoretically not susceptible to common antibiotics such as penicillin and 
its analogues. Some studies report that several bacteriostatic antimicrobial agents inhibit the 
growth of mycoplasmas, but not eradicate the contaminants. On the other hand, using of anti‐
biotics causes antibiotic‐resistant strains development [87]. The antibiotics such as aminoglyco‐
sides and lincosamides are highly effective in mycoplasma elimination. It was also found that 
tetracyclines and quinolones are highly effective against mycoplasmas. The quinolones—cipro‐
floxacin, enrofloxacin—are commercially available as mycoplasma removal agent (MRA). Other 
product—BM‐Cyclin—contains the macrolide tiamulin and the tetracyclineminocycline [88, 89].




Growth substrates The surface for cell adhesion, growth, proliferation that 
determine also cellular secretion activity of cells. Earlier the 
glass surface was widely used, now in most of laboratories 
plastic (usually polystyrene) labware is used for typical 
monolayer cultures. The surface of that cell culture vessels 
can be enhanced by coating with proteins, such as collagen, 
gelatin, laminin, fibronectin that are components of 
extracellular matrix. For that purpose also polymers can 
be used, for example, poly‐L‐lysine or other commercial 
matrices [52, 54, 79]
Media and other components
Media Are composed of two main components: a basal nutrient 
medium and supplements. The balanced salt solution, for 
example, DPBS, HBSS, EBSS, form basis of complex media. 
The supplements complete media with nutrients, proteins, 
amino acids, buffering system and vitamins. The most 
popular media are Dulbecco's Modified Eagle's Medium 
(DMEM), Eagle's Minimal Essential Medium (EMEM), 
Medium 199 (M199), Roswell Park Memorial Institute 
(RPMI–1640) or Lebovitz Medium (L‐15) [73]
Amino acids and vitamins The amino acids essential for growth and cell proliferation, 
for example, cysteine, L‐glutamine and tyrosine. For 
proper metabolism, cells require B vitamins (especially 
presence of B12 is essential), choline, folic acid, inositol, 
biotin [52, 73, 75]






‐—affect osmolarity of culture media. Trace elements 
such as zinc, copper, selenium and tricarboxylic acids 
intermediates are used in cultures madia [52, 75]
Carbohydrates and organic supplements Glucose is mainly used as an energy source [33], but in 
some cell types galactose, mammose, fructose or maltose 
can be used [56, 59]. Other sources of carbon provide 
nucleosides. The culture media can be also supplemented 
with pyruvate, lipids (cholesterol, steroids, fatty acids), 
citric acids intermediates [52, 75, 79, 80]
Serum Serum is a complex mixture of proteins, source of minerals, 
lipids, hormones, and growth and adhesion factors. Fetal 
bovine serum (FBS) and newborn calf serum (NCS) are 
most common. For more specific cultures human, horse or 
rabbit sera are used [52, 73]
Antibiotics and antimycotic solutions Antibiotics and antifungal with laminar flow hoods 
reduced the frequency of contamination. In cell cultures 
most often penicillin streptomycin solutions are used. As 
the antimycotic agents the kanamycin or amphotericin B 
are applied [52, 73, 79]
Growth factors and hormones Hormones and growth factors are used especially in 
serum‐free media. Those factors are ensured cellular 
growth, division, and differentiation. The most popular are 
fibroblastic growth factor (FGF), insulin‐like growth factor 
(IGF), vascular endothelial growth factor (VEGF) or platelet 
derived growth factor (PDGF). In the group of hormones 
the most common are hydrocortisol and insulin [52, 73, 79]
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Besides, the culture media requirements, physiochemical conditions for cell cultures should 
be properly complied. Firstly, incubator was used by Robert Koch in his microbiological stud‐
ies in the second half of the nineteenth century. Incubators were also used by Virchow, Pasteur 
or Pettenkofer in their pioneering studies [90]. Use of incubators for cell cultures was recom‐
mended by Carrel and Burrows. Working with cell cultures of “warm‐blood” animals, they 
needed to maintain proper culture temperature [67]. Earlier, some of scientists use only warm 
media to work with in vitro cultures, but this method was very unsatisfactorily. The CO
2
 incu‐
bators became widely available commercially by the 1960s [91]. Today, cell culture is main‐
tained in automated incubators that ensure proper environmental conditions—temperature, 
Factors Characteristic
Physico‐chemical properties of cultures in vitro
Potential hydrogen (pH) For animal and human cells a pH was determined in 
the range of 7.0 ‐7.4. Some differences can be noticed for 
transformed cells (7.0–7.4), and in some cases cells require 
higher pH levels, for example, normal fibroblasts (7.4–7.7). 
In the range of 6.5–7.0 cells stop growing, and between 
pH 6.0–6.5 cells losing their viability. The pH level can be 
checked by presence of phenol red in culture medium [52, 
73, 79]
Oxygen The oxygen, as a part of the gas phase is required for 
adequate cell physiology, function, and differentiation. 
The oxygen requirements are depend on the type of cells. 
In general, low concentrations of oxygen are used and 
depend on the dissolved oxygen in culture media. The 
higher concentration of oxygen can inhibit cell growth 
and metabolism. In some cases transformed cells can be 
anaerobic [52, 73, 79]
Carbon dioxide and bicarbonate The buffering system is essential to maintain proper pH. 
For establishing physiological pH for cells CO
2
 is dissolved 
in the culture medium. Carbon dioxide establishes 
equilibrium with HCO3‐ ions. The bicarbonate buffers 
not only show low toxicity, but also help in glucose 
metabolism. The other buffering system include use of 
HEPES buffer, but is was found that this system is toxic to 
some type of cells [52, 73, 79]
Temperature Generally most of cell lines are maintained at 37°C 
(earlier called “warm‐blood animal” temperature), but 
temperature is determined by origin of tissue, for example, 
lower temperature is usually used for skin and testicles cell 
cultures [52]
Osmolarity Cells exhibit rather wide tolerance to osmotic pressure. 
This factor can influence on growth and cell function. In 
general osmolatiry should be similar to the natural tissue 
environment. The osmolarites between 260 mOsm/kg and 
320 ± 10 mOsm/kg are applicable [52, 73, 79]
Viscosity The important factor for cell suspension cultured in stirred 
vessels or when cells are dissociated after trypsinization [52]
Table 2. The cell cultures environment [71, 73, 75, 79, 80].
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humidity and gaseous atmosphere (see Table 2). Most mammal cell cultures require tempera‐
ture of 37°C, CO
2
 in the range of 5–10% and relative humidity (RH) of 95% to minimize media 
evaporation and condensation [92, 93].
Development of the animal and human cell cultures would not be possible without combi‐
nation of techniques that prevent cell cultures form bacterial, fungal contaminations. The 
early safety cabinet dedicated to microbiological researches was, for the first time, presented 
in 1909 by the W. K. Mulford Pharmaceutical Co., Glenolden, Pa. The first safety cabined (a 
ventilated hood) was designed to prevent infection with Mycobacterium tuberculosis during 
the preparation of tuberculin. The earliest publication describing microbiological cabinets 
was released in 1943. Van den Ende built a safety cabinet using an electric furnace to create 
inward airflow and to incinerate the exhaust air. In the 1960s, the laminar flow clean room, 
with either horizontal or vertical airflow, was developed. The clean room environment was 
used in the pharmaceutical industry and hospitals. The clean rooms ensured the flow of fil‐
tered air over the technician and the work material. The particles present in air were trapped 
in the HEPA filter, although clean rooms that fulfilled their functions were very expensive 
and could not be relocated when it was needed. Thus, the class II safety cabinets were devel‐
oped. The principle purpose of the class II safety cabinet (laminar flow hoods, biology safety 
cabinets, BSCs) is the effective protection of personnel, the environment and the experiment 
[94, 95], for example, biological material during cell culture establishing, cells subculturing 
from micro‐organisms. Nowadays, the laminar flow hood is equipped with a HEPA (high‐
efficiency particle) filter that removes particles from air that blows into the hood. The cabinets 
are also equipped with ultraviolet light (UVC, with wavelengths between 290 and 200 nm) 
that sterilize work surface of the hood [92, 96]. The UV light is used due its physical proper‐
ties that are effective germicide and vircide. The UV light affects DNA by forming adducts 
of pyrimidine bases [96]. The main principles to avoid problems of contamination are as 
follows:
• Good aseptic technique—working with a biological safety cabinets (BSC), use of sterilized 
equipment, plasticware, glassware,
• To prevent cell cultures contamination, the copper CO
2
 incubators can be used, due to inhi‐
bition the growth of many different microorganisms (e.g., bacteria, fungi, algae, yeast). The 
copper ions disrupt key proteins and proteins essential to microbial life [97],
• Mycoplasma testing (monthly) using, for example, PCR‐based kits, DNA fluorochrome 
staining (Figure 5), autoradiography, ELISA, immunofluorescence, biochemical assays,
• Routine microscopic culture observations for microbial and yeast detection,
• Use of routine antibiotics should be avoided, and using antibiotics might cause selection of 
the resistant microbial strains,
• Regular filtering of culture media using 0.2 µm filters for protection against bacteria and 
fungi, and 0.1  µm filters to remove mycoplasma,
• Avoiding chemical contamination by testing all new lots of reagents—media, sera, trypsin, 
water,
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• Use of medical grade gases rather than industrial grade gas mixture that may contain toxic 
impurities, for example, carbon monoxide,
• To avoid cross‐contamination by other cell lines, monitoring cell culture program should 
be incorporated, for example, karyotyping, electrophoresis and isoenzyme analysis, detec‐
tion of markers using immunological or biochemical techniques, DNA fingerprinting [86, 
97, 98].
6.3. Hayflick phenomenon
In 1961, Leonard Hayflick (1928) and Paul Moorhead defined the finite life span of normal 
human cells. Hayflick inspired by Carrel's observations started research on the possible viral 
etiology of human cancer [99, 100]. Firstly (in 1958), normal human embryonic cells were 
exposed to cancer‐cell extracts. Hayflick expected that normal cells would change and dis‐
play cancer‐like properties, but normal cells did not grow any longer. Hayflick thought that 
he made a mistake in culture medium composition, glassware cleaning or other technical 
procedures. A few years later (in 1961), when working with the cytogenetist Paul Moorhead, 
he performed a series of experiments that validated Carrel's theory. In their work, they 
demonstrated that normal human fibroblasts doubled a finite number of times, stopped 
dividing and entered the phase III phenomenon. Hayflick divided the time of primary cell 
culture into three phases [99, 100]. Phase I—“or the primary cell culture that terminates 
with the formation of the first confluent sheet.” Phase II—“is characterized by luxuriant 
growth necessitating many subcultivations” [99]. This phase takes about ten months, and 
the cells in this phase are termed “cell strains” [99, 100]. Finally, the cell strain enters Phase 
III. In phase III, the cells stop dividing, and the cell strain is lost after a finite period of time. 
On the basis of these experiments, Hayflick argued that normal cells have a finite capacity 
to replicate as opposed to cancer cells (e.g., HeLa cell line) that are immortal and display 
indefinite growth [99, 100].
Hayflick and Moorhead findings revised Carrel's idea of cellular immortality. Due to evidence 
of defined life span of normal cells, Dr. Witkowski conducted his own private investigations 
to find the answer to the phenomenon of Dr. Carrel's immortal cells. In his publication, he 
Figure 5. Photomicrographs (400×) of bovine mammary epithelial cells stained with DAPI dye. The clean culture (A) [14] 
and the infected culture (B) [unpublished, Jedrzejczak‐Silicka].
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presented three theories to explain why the culture obtained by Carrel and his coworkers 
was maintained in vitro for 34 years. The first hypothesis presented the “cell transformation 
theory.” It is known that transformation can occur spontaneously and can also be induced by 
oncogenic viruses, but it is also established that spontaneous transformations occur particu‐
larly often in murine cell cultures and are extremely rare in chick cells. The transformed cells 
usually display changes in morphology and behavior, but Carrel's cells were described as 
being unchanged in appearance. Thus, Witkowski raised a question—“could the ‘immortal’ 
cells have been a spontaneously transformed cell line?” [67]. The second theory concerns cell 
contamination. The “immortal strain” was cultured using embryo extract, and Hayflick also 
noted that periods of intense cell growth corresponded to the occasions on which embryo 
extract was incorporated in the culture medium [67, 99]. Hayflick suggested that embryo 
extract contained living cells, and those cells grew and gave the impression that the original 
cells were stimulated by the extract. The question is Could Alexis Carrel replenish his cultures 
with “young” cells? [67]. The third theory was the “re‐stocking” theory. It was suggested that 
the “immortal cells” could originate from intentionally replenished cell culture population by 
Carrel's technicians [67]. The presented theories tried to explain the phenomenon of Carrel's 
culture.
7. Immortality of HeLa cell line
In 1951, Henrietta Lacks was diagnosed with aggressive adenocarcinoma of the cervix by Dr. 
Jones at Johns Hopkins Hospital in Baltimore. After cervical biopsy, the samples were send 
to Dr. George Gay (1917–1994)—director of the Tissue Culture Laboratory [52]. His assistant, 
Mary Kubicek, first noticed that the cells remained viable in a nutrient solution of chicken 
plasma [101, 102]. She placed Lacks’ specimen into the culture medium and cultured in roller 
tubes. Established cell cultures grew robustly, were durable and divided every 20 h. This cell 
line was called HeLa (derived from patient's name—Henrietta Lacks), but for years, HeLa 
cells were also interpreted as originating from Harriet Lane or Helen Larsen [71, 101, 102]. 
This situation was associated with confidential information about the originator of HeLa cells, 
and it was until the Obstetrics and Gynecology named Henrietta Lack as the HeLa cell source 
in 1971 [101–104].
In 1952, Dr. Gay and his coworkers published the results of 1‐year HeLa cultures. They stated 
that they had established and maintained “continuous roller‐tube cultures for almost a year” 
[105]. It was demonstrated that the cells of HeLa line grew in various media—in chicken 
plasma medium, bovine embryo extract and human placental cord serum [102, 105]. HeLa cell 
line established by Gay gave Jonas Salk and John Enders possibilities to develop poliovirus 
cultures in a non‐nervous tissue system [71, 101, 102]. The poliomyelitis virus was success‐
fully propagated in HeLa cell cultures by Dr. Gay [102]. HeLa cell line was cultured in almost 
all known culture media and was rapidly distributed to the laboratories in the United States 
and other countries to scientists who were interested in cancer studies. HeLa cell line was also 
distributed to pharmaceutical companies, and thus, HeLa cells became the most popular and 
valuable resource for cancer studies [96, 102].
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The most famous cell line was studied intensively, in particular the mechanisms that made it 
so aggressive. Currently, it is known that HeLa cells were infected with human papillomavi‐
rus 18 responsible for protein synthesis that degrades the protein of the p53 tumor suppres‐
sor gene [101]. HPV18‐positive HeLa cells displayed changes in microRNA expression [102]. 
It was also found that HeLa cells had a mutation within Lacks’ HLA supergene family on 
chromosome 6 [101]. In 2013, HeLa genome was fully sequenced and published without the 
knowledge of Lack's family (later, the family has endorsed restricted access to HeLa genome 
data) [103]. Groups from the European Molecular Biology Laboratory and the Institute of 
Human Genetics (Heidelberg, Germany) determined that the insertion of HPV18 was located 
on chromosome 8 [106, 107]. This result was consistent with previous studies, but addition‐
ally, nine putative viral integration sites were found. It was also discovered that four of the 
HeLa chromosomes had been shattered and reassembled into highly rearranged chromo‐
somes. The term “chromothripsis” was introduced to define the described phenomenon, and 
it was found to be associated with 2–3% of all cancers. The presence of chromothripsis was 
also confirmed especially in chromosome 11 [106, 107]. Other rearrangements were observed 
on chromosomes 5, 19 and X. The chromothripsis process is also manifested in a high number 
of CN (copy number along the genome) switches, high interconnectivity and alternations 
between a low number (2–3) of CN states [106–110]. The comparison of transcriptomes of 
HeLa with normalized gene expression levels of 16 tissues (from Illumina Human BodyMap 
2.0) showed that 1907 genes, of which 805 genes were protein‐coding, were more highly 
expressed in HeLa cells. Finally, 23,966 genes, of which 5593 were protein‐coding, were not 
found to expressed in HeLa cells [107].
In the light of the results presented by Landry and his coworkers, the suggestion of the biolo‐
gist Van Valen made in 1991 that HeLa cells have become new species—Helacyton gartleri—as 
a result of countless cell passages, viral infections or other cell line contaminants seem to take 
on a new importance [102, 111, 112].
8. Immortalization of cells and first monoclonal antibodies
In cell cultures, the transformation may occur spontaneously, and immortal cell populations 
were observed in many laboratories from the early 1940s to the early 1960s [113]. Immortal 
cells arise spontaneously from normal cells, and murine cell cultures are especially prone to 
that process [67, 117]. Cell cultures can be transformed by oncogenic viruses, for example, 
SV40 [115, 116] or by radiation (x irradiation) [114, 117] and chemical carcinogens, for exam‐
ple, methylocholanthracene [64, 118]. Hayflick defined the immortality term as a”life form 
capable of indefinite survival in conditions where no changes have occurred in molecular 
composition from some arbitrary beginning” [119].
Cell culture observations in the fifties brought the conclusions that cells derived from, for 
example, skin and muscle exhibit contact inhibition of growth. Other findings were made 
for cells infected with the Rous sarcoma virus. In that case, cell growth was not arrested, and 
it was the first evidence of cells’ transformation by oncogenic retroviruses. The dense focus 
assay was widely used to describe oncogenic activity and indicated that the transformed 
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cells displayed the ability to continue proliferate even after they reached confluence. In stud‐
ies focused on the transformed cells, it was also noted that those cells were able to form a 
multilayer on top of normal cells. It was also argued that the loss of contact inhibition was 
correlated with tumorigenicity. The transformed cells were able to anchorage‐independent 
growth and proliferate in the absence of serum in medium [120]. Working with SV40, sci‐
entists developed a model‐transforming virus. SV40 was used for transformations of many 
different animal and human cell cultures, for example, 3T3 cell line was established [117, 120, 
121]. The mechanisms that play a crucial role in immortalization and transformation are not 
very well defined, but several cell lines provide evidence that telomere maintenance, pRB and 
p53 tumor suppressor protein pathways are important in these processes [120].
The first hybrid mammalian cells were obtained via viral fusion in human and mouse cells 
in 1965 by Harris and Watkins. In their work, they demonstrated that fusion of cells of differ‐
ent species was possible [122]. Using a new technique of UV inactivation, Harris and Watkins 
obtained heterokaryons from human HeLa cells and Ehrlich ascites tumor cells from mice [123].
Firstly, monoclonal antibodies were produced by Georges Köhler and Cesar Milstein in 1984 
[52]. They described derivation of a number of culture cell lines that were able to secrete anti‐
sheep red blood cell (SRBC) antibodies. Cell fusions were obtained using mouse myeloma 
and mouse spleen cells from an immunized donor. For cell fusion, two myeloma cell lines 
derived from BALB/c mice were used. The P1Bu1 cell line was resistant to 5‐bromo‐2′‐deoxy‐
uridine and did not grow in the HAT selective medium. Thus, the cell line secreted a myeloma 
protein—IgG2A. The second cell line was P3‐X63Ag8, derived from P3 cells resistant to 8‐aza‐
guanine, and did not grow in HAT medium. The P3‐X63Ag8 secreted MOPC 21–IgG1 (κ). Cell 
fusion was performed using an inactivated Sendai virus. The karyotype of hybrid cells (after 
4 months) was lower than the sum of the two parental cell lines. After cell fusion by Sendai 
virus, the cells of P3‐X63Ag8 line were able to growth in HAT medium and secreted immuno‐
globulins that contained MOPC 21 protein [124, 125].
Through research conducted by Köhler and Milstein, medicine and science obtained mono‐
clonal antibodies as a very useful tool for research and diagnosis that can be used in the treat‐
ment of different diseases, for example, rheumatoid arthritis, cancer, cardiovascular diseases, 
transplantations or infectious diseases [126–128]. For this reason, in 1984, The Nobel Assembly 
of Karolinska Institutet decided to award the Nobel Prize in Physiology or Medicine to Niels 
K. Jerne, Georges J.F. Köhler and César Milstein for theories related to “the specificity in 
development and control of the immune system” and the discovery of “the principle for pro‐
duction of monoclonal antibodies” [128].
9. Production of therapeutic proteins in mammalian cell cultures
On the basis of knowledge about the cell cycle and gene expression regulation, in 1986, the 
first therapeutic protein—recombinant tissue‐type plasminogen activator (tPA, Activase; 
Genentech, San Francisco, CA, USA)—was obtained in the culture of immortalized Chinese 
hamster (Cricetulus griseus) ovary (CHO) cell line [129, 130]. In addition, many other recom‐
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binant protein pharmaceuticals are expressed in CHO cells and other cell lines, such as 
mouse myeloma (NS0), baby hamster kidney (BHK) or human embryo kidney (HEK‐293). 
It was estimated that about 60–70% of all recombinant proteins are produced in mamma‐
lian cells [129, 131, 132]. Cells used in the recombinant protein synthesis maintain a recom‐
binant gene (with key transcriptional regulatory elements) and a selection gene. The most 
popular genes for selection process are dihydrofolatereductase (DHFR), which encodes an 
enzyme involved in nucleotide metabolism and glutamine synthetase (GS) responsible for 
the expression of an enzyme that catalyzes the synthesis of glutamine from glutamate and 
ammonia [129].
The production of recombinant proteins in mammalian cells can be performed in two main 
forms: adherent cell cultures and suspension cell cultures [129]. The example of adherent 
cells widely used in protein production is the CHO cell line [133]. This immortalized cell line 
was established by Dr. Puck in his laboratory (at the Eleanor Roosevelt Institute for Cancer 
Research) in 1957. For establishing primary cell cultures, 0.1 g of ovary tissue of Chinese ham‐
ster was used. After the trypsinization process, cell culture was described as predominantly 
of fibroblast type, with a near diploid karyotype (only about 1% of the cell population had a 
different number of chromosomes, more or less than 2n = 22). This small difference in diploid 
character of primary cells is generally rare in primary cells of full diploid karyotype. After some 
time from establishing the culture, the morphology of cells changed, and it seemed that the cell 
culture underwent spontaneous immortalization. After further 10 months of the culture, other 
morphological changes were observed. Recloning of these cells with a modified morphology 
(from fibroblast‐like to more epitheloid) resulted in the cell line known as CHO (or CHO‐ori) 
[134]. The CHO cells were used for the first time in biotechnology after establishing the CHO‐
DXB11 cell line. This cell line established by Dr. Chasin carries a deletion of one DHFR locus 
and a missense mutation (T137R) of the second locus. Those changes made the cells totally 
incapable of the reduction of foliate to dihydrofolate (DHF). This cell line was a system for the 
production of human tPA in a roller bottle system. The cells are grown attached to the inner 
wall of the bottle filled with culture medium to 10–30% of its normal volume. The bottles are 
slowly rotated to assure oxygen supply and to wet the cells [129, 134]. Among other pharma‐
ceutical proteins produced using CHO cultures are Epogen (erythropoietin), ENBREL (a TNF 
inhibitor) or HERCEPTIN (an anti‐HER2 breast cancer antibody) (see Table 3) [129, 134, 135].
To scale‐up production bioprocesses, adherent cells can also be cultivated in stirred‐tank bio‐
reactors. For anchored‐dependent cells, (e.g., CHO) polymer microcarriers are used, and fol‐
licle‐stimulating hormone and virus vaccines were produced this way [129].
The second form of the production of recombinant proteins in mammalian cells is a suspen‐
sion culture. CHO cells are also capable of growing as a single‐cell suspension. Cell lines, 
such as NS0, BHK, HEK‐293 or PER‐C6 (human retina‐derived), are grown in suspension. 
Suspension cultures are optimized for a high‐density cell culture in the absence of serum or 
other animal‐derived components. In some procedures, the reduction of the temperature (to 
30–33°C) and increased osmolarity are used to enhance the production process [129, 136]. 
Production on a higher scale is possible by using bioreactors. The main types of mammalian 
cell cultures are batch, fed batch, repeated batch, continuous and perfusion cultures [137].





Type Therapeutic use Manufacturer FDA approval





Epogen Erythropoietin Anemia Amgen 1989
Pulmozyme Deoxyribonuclease I Cystic fibrosis Genentech 1993
Cerezyme β‐Glucocerebrosidase Gaucher's disease Genzyme 1994
Avonex Interferon‐β Relapsing multiple 
sclerosis
Biogen Idec 1996
Rituxan Anti‐CD20 mAb Non‐Hodgkin's 
lymphoma
Genentech, Biogen Idec 1997
Follistim Follicle stimulating 
hormone (FSH)
Infertility Serono 1997
Benefix Factor IX Hemophilia B Wyeth 1997
Herceptin Anti‐HER2 mAb Metastatic Brest cancer Genentech 1998
Tenecteplase Tissue plazminogen 
activator (engineered)
Myocardial infraction Genentech 2000




Humira Anti‐TNFα mAb Rheumatoid arthritis Abbott 2002
Raptiva Anti‐CD11a mAb Chronic psoriasis Genentech 2003
Xolair Anti‐IgE mAb Moderate/severe asthma Genentech 2003
Avastin Anti‐VEGF mAb Metastatic colorectal 
cancer
Genentech 2004
Luveris Luteinizing hormone 
(LH)
Infertility Serono 2004
Aldurazyme Laronidase Mucopolysaccharidosis Genzyme 2006
Myozyme α‐Gluosidase Pompe disease Genzyme 2006
Vectibix Anti‐EGFR mAb Metastatic colorectal 
cancer
Amgen 2006
Denosumab Anti‐RANKL mAb Osteoporosis, giant cell 
tumor of bone
Amgen 2010
Ipilimumab Anti‐CTLA4 mAb Melanoma Bristol‐Myers Squibb 2011
Table 3. List of biotherapeutics approved by FDA produced in Chinese Hamster Ovary cell lines [131, 136].
Finally, mammalian cell culture ensures most often consistent glycosylation patterns and rela‐
tively homogeneous (in comparison with E. coli, yeast, baculovirus expression vector systems, 
but with minor differences between different species of cell host) [138]. The consistent gly‐
cosylation profile maintained between batches is crucial for the recombinant biotherapeutic 
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protein production, but the extent of glycosylation may decrease over time in a batch culture. 
The depletion of nutrients (e.g., glucose or glutamine) is the reason of limit for the glyco‐
sylation process, and thus, the fedbatch strategies should ensure proper concentrations of 
key nutrients to avoid their decrease to a critical level that could compromise protein glyco‐
sylation. Some studied presented that the pattern of protein glycosylation is dependent on 
the expression of various glycosyltransferase enzymes that occur in the Golgi of the cell and 
display different relative activity among species. Those differences can account for significant 
variations in structure. Complete glycosylation process is usually associated with maximiza‐
tion of two processes—galactosylation and sialylation that usually are incomplete and result 
in glycan structural variation. An alternative approach involves glycoengineering of the pro‐
teins in vitro [139].
10. Phenomenon of induced pluripotent stem cells (iPS)
In 2006, Shinya Yamanaka and his colleagues demonstrated that reprogramming of adult 
mouse tail‐tip fibroblasts toward embryo stem cells by simultaneously induced expression of 
four transcription factors—Oct3/4, Sox2, Klf4, and c‐Myc—was possible. Reprogrammed cells 
were selected by the presence of Fbx15 gene expression, which is characteristic of early devel‐
opment and embryo stem cells. The induced pluripotent stem cells (iPSCs) exhibited traits of 
mouse ES cells but also showed differences in gene expression and chromatin organization 
in comparison with ES cells [140, 141]. Later, researchers have shown that the selection for 
Nanog expression after transduction of four factors (Oct3/4, Sox2, Klf4 and c‐Myc) resulted in 
obtaining a more similar population of cells to ES cells. After that experiment, another discov‐
ery was made by Yamanaka and his coworkers. They introduced mouse retrovirus receptor 
into human cells to obtain higher transduction frequency by amphotropic retrovirus. With 
this procedure, 60% of cells exposed to the retrovirus expressed a reporter gene. Then, the 
same four genes were introduced into adult human dermal fibroblasts, and the first human 
iPS was created. The selection was based on morphology and growth characteristics of these 
cells. It was also found that each clone of iPS carried from three to six retroviral integrations 
for each of four factors. The very important trait of human iPS was the capacity to form tissues 
of all three germ layers in tissue cultures and transplantations (into immune‐deficient mice) 
[140]. The authors stated that the reprogramming process is unknown, but they suggested 
that Oct3/4 and Sox2 upregulated the expression of genes related to pluripotency. These two 
genes upregulate “stemness” genes in both human and mouse ES cells. On the other hand, c‐
Myc and KIf4 may alter chromatin structure modifications, thereby granting Oct3/4 and Sox2 
access to crucial target genes [140–142]. It has also been found that KIf4 interacts with p300 
histone acetyltransferase and plays a role in gene transcription regulation via histone acetyla‐
tion. The role of c‐Myc is the induction of differentiation and apoptosis of human ESC, but the 
same gene in mice plays a positive role in ES [142].
Other group of scientists—Thomson and his colleagues—demonstrated that pluripotency in 
human fibroblasts can be obtained by reprogramming of OCT4 and SOX2 with NANOG and 
LIN28 genes in human somatic cells of mesenchymal phenotype [140, 143]. Effective repro‐
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gramming was also evaluated in primary, genetically unmodified human fibroblasts—IMR90. 
The IMR90 cells were transduced with a combination of four genes (OCT4, SOX2, NANOG and 
LIN28), and after 12 days, the colonies of cells displayed human ESC morphology. The cells had 
normal karyotype and were verified by the presence of cell surface markers and genes typical 
for ESC. The induced cells were able to differentiate into embryoid bodies and teratomas [143].
Firstly noticed that the differences between iPSC and adult human cells were morphol‐
ogy and growth characteristic. Before 2009, the human iPS cells were described as highly 
similar to human embryonic stem cells (ES), and those similarities included morphology, 
proliferation, expression of cell‐surface markers, gene expression (with the telomerase 
expression) and chromatin organization [140]. In 2009, Chin and his colleges [144] pre‐
sented results obtained from the comparison of three human ESC lines and five iPSC lines. 
They reported differences in hundreds of genes expression. Deng et al. [145] and Doi et al. 
[146] reported differences in DNA methylation and indicated that epigenetic memories of 
donor cells in human iPSC [141].
Induced pluripotent stem cells (IPSCs) are genetically identical to the mature body cells from 
which they were derived. It was noticed that the same genes are chemically altered in stem cells 
derived from adult cells, when cells undergo differentiation, and also when the normal cells 
become cancer cells. The iPSCs display ability to self‐renew and differentiate to every type of 
cells. The difference between adult and iPSCs is subtle. The study that focused on fibroblasts and 
the pluripotent stem cells into which they were reprogrammed shows that difference was classi‐
fied as epigenetic (it was described as—what gets copied when the cell divides, although it is not 
the part of the DNA sequence). It is due chemical change—methylation that is associated with 
silencing genes. During that study, differentially methylated regions (DMRs) of genes whose 
expression was changed in the process of being reprogrammed from a parent cell to a stem cell 
were identified. The process of reprogramming an adult cell to a stem cell involves DMRs and 
genes. Studies based on cancer cell showed that differently methylated sites were located in can‐
cer cells which matching up with many of the methylated areas that had been implicated during 
differentiation processes of normal tissues [146]. It was stated that there is the high degree of 
overlap between the differently methylated regions and genes that are involved in reprogram‐
ming fibroblasts into stem cells and also reprogramming a normal cells into a cancer cells [146].
In 2012, the Nobel Prize in Physiology and Medicine was awarded to John B. Guordon (for 
the discoveries that proved reversible nature of cell specialization) and Shinya Yamanaka 
(for reprogramming mature mouse cells to immature cells) [147, 148]. Both discoveries are of 
great importance in many areas of medicine, for example, oncology and regenerative medi‐
cine. It was reported that ESC were successfully used in cartilage repair, peripheral nerve 
repair or cardiac regenerative therapy. Moreover, MSC were used in certain types of thera‐
pies, for example, autologous transplantations or hematopoietic disease therapies [148].
11. 3‐D bioprinting technology
ECM (extracellular matrix) development allows to obtain cell‐cell and ECM‐cell interactions 
in cultures [52]. Using 2‐D cell cultures, the researchers were not able to mimic in vivo state. 
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The classical monolayer cultures have various limitations, for example, loss of tissue spe‐
cific architecture, cell‐cell interactions [56, 57]. The new techniques development helped to 
improve cell cultures microenvironment, for example, three‐dimensional (3D) cell culture 
models. This technique gave possibility to achieve non‐adherent (anchorage‐independent) 
and adherent (anchorage‐dependent) cell cultures. For anchorage‐independent cultures, the 
cell aggregation can be achieved by using low‐attachment surface dishes and/or coated with 
agarose and poly‐hydroxyethyl methacrylate (pMEMA). The 3‐D cultures of the anchorage‐
dependent cells can be obtained by using porous materials for prefabricated scaffolds that 
support adherence of cells [52]. The 3‐D culture format gives unique possibility to analyze 
and to understand tumor cell growth, migration, therapy resistance. The culture of multi‐
cellular tumor spheroid (MCTS) for anticancer drug screening was developed. For this cell 
model, chitosan/collagen/alginate (CCA) fibrous scaffold was used, and such 3‐D model gave 
important information about metastatic spread of carcinoma cells [56, 149]. The 3‐D culture 
technique is based on the idea to mimic and has many advantages, but this relatively new and 
innovative technique displays some limitation and disadvantage that are summarized below:
The advantages are as follows:
• More representative in vitro model that exhibits biochemical and morphological features 
specific for the in vivo state,
• 3‐D culture ensure cell‐cell and cell‐ECM interactions (mechanical and biochemical sig‐
nals) that are essential for different processes such as differentiation and proliferation,
• This type of cultures ensure more accurate tissue‐specific architecture,
• More accurate for drug and cancer biology experiments [56],
• Different types of 3‐D cell culture systems, for example, 3‐D spheroids grown on matrix, 
3‐D spheroids grown within matrix (scaffold‐based 3‐D culture), 3‐D spheroids grown in 
suspension, scaffold‐free 3‐D culture [77, 150].
The disadvantages are as follows:
• Some matrices used for 3‐D cultures are animal‐derived or human‐derived and have com‐
ponents (often unwanted such as growth factors or viruses) from that reason implementa‐
tion for clinical work is difficult (risk the potential transmission of diseases),
• In some 3‐D cultures, detachment of cells is difficult,
• Some existing systems fail to mimic the biomechanical characteristics of tissue in vivo rep‐
resent a static condition [150],
• For scaffold‐based culture systems, reproducibility between different batches is 
unsatisfactory,
• In synthetic scaffolds PEG‐based, PEG is cell compatible but inert; cells that are embed‐
ded are not able to attach to the matrix without modifications (e.g., RGD‐sites covalently 
attached to PEG hydrogels),
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• Difficulties in encapsulated cells recovering (e.g., for isolation of nucleic acids or protein), 
screening and bioprocessing in 3‐D culture systems like imaging tools are difficult, for 
example, autofluorescence of collagenous scaffold [150].
Progress in 3‐D cell culture technology created the possibility of tissue engineering devel‐
opment and enhanced progress in the regenerative medicine [52]. Firstly, tissue‐engineered 
cartilage was developed in nineties, and in 2013, the ear was printed using a hydrogel to form 
an ear‐shaped scaffold and cells that formed cartilage [151]. The 3‐D bioprinting technology 
is one of most intriguing innovation, but the idea of 3D printing is not new. The first descrip‐
tion of 3‐D printing was made by Charles W. Hull that he called his method “sterolitography” 
[152–155]. The formation of 3‐D scaffolds for biological materials was the first step in the 
development of that technology. The next step was to evaluate technique that allows to print 
living cells layer‐by‐layer into special 3‐D scaffolds [153].
The 3‐D bioprinting technology depends on many elements such as inkjet, microextrusion 
and laser‐assisted printing. The first inkjets printers used for bioprinting were modified ver‐
sion of widely available 2‐D ink‐based printers. In the cartridge, the ink was replaced with 
a biological material, and the paper with a stage with controlled elevator to control of the 
xyz axis. Now, inkjet printers for bioprinting applications use thermal or acoustic methods 
to eject drops of bioink onto substrate. The other crucial element of bioprinting is the micro‐
extrusion that usually consists of a material‐handling system, dispensing system and the 
stage. The function of the microextrusion printers is to control extrusion of small bead of 
material, which is deposited onto substrate. The extrusion of material can be controlled by 
pneumatic or mechanical dispensing systems. The third important factor in organ or tissue 
printing process is laser‐assisted bioprinting (LAB). The LAB device consists of a pulsed laser 
beam, a focusing system, a “ribbon” that provides transport of material, and substrates for 
cell‐containing material. The materials used in regenerative medicine and 3‐D bioprinting are 
based on natural (e.g., alginate, collagen, chitosan, fibrin) or synthetic polymers (e.g., PEG). 
Materials should be characterized by good printability, high biocompatibility, known degra‐
dation kinetics and byproducts, material biomimicry and proper structural and mechanical 
attributes [153].
The successful bioprinting process depends on cells selection for tissue or organ printing. 
Printing organs or tissues requires multiple cell types, for example, the primary functional cells, 
embryonic and induced pluripotent stem cells. The cells chosen for bioprinting must be robust 
to survive the printing process, and thus, in many studies, cell lines are used. For example, 
fibroblast or transformed cell lines are robust enough to shear stress and pressure [153, 155].
The progress in bioprinting manifests in obtained 2‐D tissue such as skin, hollow tubes (e.g., 
blood vessels, trachea), organs as the bladder or solid organs such as the kidney [153].
The organ and tissue printing will not only solve problem of organ transplantation but will 
give possibilities to use those construct in drug discovery, chemical, biological or toxicologi‐
cal analysis, and cancer research [153, 156]. For example, the cancer 3‐D tissue model was 
obtained for human ovarian cancer (OVCAR‐5) cells and normal fibroblast [156].
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12. Future of cell cultures
The future of animal cell technology will enlarge its applications, for example, use of viral 
vectors for gene therapy, vaccine technology, recombinant protein production for therapeutic 
purposes. Moreover, human cell cultures can also be used for personal therapies—gene thera‐
pies, tissue engineering, transplantation of organs. In the future, more human diseases will be 
treated by new form of therapies based on organ and tissue cultures [74].
Since HeLa established, immoral cancer cell lines are intensively studied as a biological 
models to investigate cancers biology (e.g., cancer initiation, progression, metastasis, tumor 
microenvironment and cancer stem cells) and evolved anticancer drugs or alternative form 
of therapy, for example, hyperthermal therapy, use of nanoparticles. However, many results 
obtained from the examination of immortal cancer cell lines suggest that cancer cell lines 
are not representative, due to cancer heterogeneity and drug‐resistant tumors occurring in 
patients [157]. To solve the problems with the present standard therapy (“one treatment fits 
all”), two elements should be realized. The first one, that is based on the idea—“health is 
a molecular thing,” that focused on genome‐based studies and biomarkers analyses that 
will expand the range of diagnostic, and the cancer patients will be treated with the optimal 
targeted therapy [157, 158]. For example, form of personalized medicine was presented by 
Thomas Blankenstein and Wolfgang Uckert (Berlin Institute of Health) who are working on 
a T‐cell therapy (using genetically modified T cells) that specifically targets mutations (muta‐
tions that lead to errors in the mechanisms that control cell division) in the genome in order to 
fight tumors [159]. The second one includes the derivation and short‐term culture of primary 
cells from solid tumors to evaluate or improve personalized cancer therapy [157].
Studies with cancer cell lines give opportunity to understand of tumor biology and allow 
high‐throughput screening for drug development. Although many important investigations 
were performed using cancer cell lines, the results give limited information and present low 
clinical correlation. The genetic aberrations of cancer cell lines that are related with increasing 
passage numbers are one of the reasons why this type of study does not fully represent clini‐
cal situation. Thus, primary tumor cell cultures (e.g., 3‐D tumor culture derived from solid 
tumor specimens) can give more accurate information about individual cancer cases and sup‐
port establishment of clinical setting [157, 160].
Due to specify of cancer cells, different therapeutic strategies should be chosen, for example, 
monoclonal antibodies, radiotherapy, chemotherapy, small molecule inhibitors, targeted 
therapies or combinations of two, three forms of treatment. Information about the”specify of 
cancer cells” is complex and includes not only tumor microenvironment and signalling path‐
ways analyses, but also patient‐specific tumor cultures for drug profiling prior to adequate 
clinical treatment selection [157].
Future medicine will able to use widely stem cells [adult and as well human embryonic stem 
cells (HESC)] for damage tissue replacement [74]. The idea of Dr. Atala's of in situ bioprinting 
therapy and the results obtained in that area are promising. It was presented by Albanna and 
his colleagues that “the skin bioprinter is able to deliver two different types of skin cells and 
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biomaterials directly on target locations and cover skin wounds and defects.” It is possible 
that in the near future, use of skin bioprinters will be a useful tool in surgical reconstruction 
and a preferred form of therapy in wound and burns treatment [161].
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